Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

Completed

• Conditions: Neuralgia

• Registration Number: NCT00541476
• Lead Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Brief Summary

The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-06
• Study First Submitted: 2007-10-08
• Study First Submitted QC: 2007-10-08
• Study First Posted: 2007-10-10
• Primary Completion: 2007-12
• Study Completion: 2007-12
• Status Verified: 2008-11
• Last Update Submitted: 2021-01-21
• Last Update Posted: 2021-01-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 746

Inclusion Criteria

• Clinical diagnosis of peripheral or central neuropathic pain

Exclusion Criteria

• None. Patients recruited by physician decision. Patient's personal data are not collected.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified